Has John Chi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $11,284 in general payments to John Chi, MD across 51 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Chi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Chi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Chi, MD

Plastic Surgery within the Head & Neck · Creve Coeur, MONPI 1689872368

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (44.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Synthes GmbH accounts for 75.9% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2024 at $6,227 and has fallen 99.8% since, to $15 in 2025.

$11,284in general payments, 2019–2025

Across 51 payments — averaging $221.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Synthes GmbH$9K
Kuros Biosciences USA, Inc$900
Stryker$690
Organogenesis Inc.$478
Kls-martin L.p.$183
Johnson & Johnson$148
plus $319 from 6 others

What the payments were for

Consulting fees$9008%
Speaking & faculty fees$5,00044%
Travel & lodging$3,16828%
Food & beverage$2,21620%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Synthes GmbH	13	$8,567
Kuros Biosciences USA, Inc	1	$900
Stryker	7	$690
Organogenesis Inc.	15	$478
Kls-martin L.p.	2	$183
Johnson & Johnson	2	$148
AbbVie	1	$119
Olympus America Inc.	3	$58
Ambu Inc.	2	$43
KARL Storz Endoscopy-america	2	$40
Zimmer Biomet	1	$32
Smith+Nephew	2	$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few plastic surgery within the head & neck providers in Missourito place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$82,444

Medicare patients

Services billed

1,416

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other plastic surgery within the head & neck in Creve Coeur

Gregory BranhamCreve Coeur$1K
Craig BuchmanSaint Louis$534K
Laxmeesh NayakSaint Louis$71K
James BoydSaint Louis$2K
Mark PackerSaint Louis$2K
John BarclayLiberty$1K
Michael BaysBranson$460

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →